DaVita to present three abstracts on Peritoneal Dialysis at the ISPD meeting

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

ISPD provides leading renal health care providers with the opportunity to advance their knowledge of peritoneal dialysis (PD) and to promote advancement of such knowledge through international meetings and scientific publications.

The presentations will highlight subjects critical to physicians, nurses and other practitioners in the field of PD, including:

• A DaVita(R) pilot program evaluating ESA use in PD patients and how to ensure patient adherence while maintaining hemoglobin outcomes;
• Access to Peritoneal Dialysis: Overcoming Obstacles for Uninsured, Unencountered Patients - a look at how changes in PD clinic infrastructure and the industry's perception would increase usage of this valuable treatment method;
• The Post-Peritonitis Checklist: Beyond Pharmacological Treatment - an analysis of the impact implementing a step-by-step checklist of pre-existing and innovative interventions into patient care practices resulted in reduced peritonitis rates.

"DaVita is committed to leading the renal community in seeking out new and innovative ways to improve clinical outcomes for patients with kidney disease," said Allen R. Nissenson MD, Chief Medical Officer at DaVita. "The three abstracts being presented at this meeting reflect DaVita's success in driving quality improvement for patients."

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.